Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia.
Extensive hepatocellular adenomatosis (HA) and focal nodular hyperplasia (FNH) represent a proliferation of hepatic cells that occurs most frequently in women. These lesions are uncommon in the pediatric age group, accounting for 2% of pediatric hepatic tumors, and are extremely rare in males. The etiology of HA and FNH has been correlated with the use of oral contraceptives. We report to the best of our knowledge the first series of patients treated with OLTx for HA and FNH (five cases). All these patients had lesions involving at least 90% of the hepatic parenchyma and all underwent major hepatic surgery before OLTx because of life threatening complications. One patient died in the immediate postoperative period following retransplantation for primary non-function of the first OLTx. Four out of five patients are currently alive from 4.1 to 9.6 years after OLTx. Our results justify the use of OLTx for symptomatic patients with HA and FNH who cannot be treated with conventional hepatic resections.
Marino
I R
IR
Department of Surgery, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
Scantlebury
V P
VP
Bronsther
O
O
Iwatsuki
S
S
Starzl
T E
TE
D018248:Adenoma, Liver Cell / Q000601:surgery*; D000328:Adult; D005260:Female; D020518:Focal Nodular Hyperplasia / Q000000981:diagnostic imaging / Q000601:surgery*; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D008875:Middle Aged; D011788:Quality of Life; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome